Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels

American Journal of Medicine

Volumn 109, Issue 1, 2000, Pages 62-64

  Nutt, Angela K ^a   Hassan, Hassan A ^a   Lindsey, Judy ^a   Lamps, Laura W ^a   Raufman, Jean Pierre ^a  

^a UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0034725761     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00381-8     Document Type: Article

References (16)

1. Management of Hepatitis C. NIH Consensus Statement. 1997;15:1-41.
2. Di Bisceglie A.M., Goodman Z.D., Ishak K.G., et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 14:1991;969-974.
3. Esteban J.I., Lopez-Talavera J.C., Genesca J., et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med. 115:1991;443-449.
4. Alberti A., Morsica G., Chemello L., et al. Hepatitis C viraemia, and liver disease in symptom-free individuals with anti-HCV. Lancet. 340:1992;697-698.
5. Van Thiel D.H., Caraceni P., Molloy P.J., et al. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels. The role of interferon α2b therapy. J Hepatol. 23:1995;503-508.
6. Gholson C.F., Morgan K., Catinis G., et al. Chronic hepatitis C with normal aminotransferase levels. A clinical histologic study. Am J Gastroenterol. 92:1996;1788-1792.
7. Brillanti S., Foli M., Gaiani S., et al. Persistent hepatitis C viraemia without liver disease. Lancet. 341:1993;464-465.
8. Naito M., Norio H., Hagiwara H., et al. Serum hepatitis C virus RNA quantity, and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology. 19:1994;871-875.
9. Heintges T., Mohr L., Hensel F., et al. Value of liver biopsy prior to interferon therapy for chronic viral hepatitis. Dig Dis Sci. 43:1998;1562-1565.
10. Mathurin P., Moussalli J., Cadranel J.F., et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine aminotransferase activity. Hepatology. 27:1998;868-872.
11. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
12. Koretz R.L. Making end points meet. Gastroenterology. 116:1999;1266-1267.
13. Serfaty L., Chazouilleres O., Pawlotsky J.M., et al. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology. 110:1996;291-295.
14. Rossini A., Ravaggi A., Biasi L., et al. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis. Hepatology. 26:1997;1012-1017.
15. Sangiovanni A., Morales R., Spinzi G.C., et al. Interferon alpha treatment of HCV RNA carriers with persistently normal aminotransferase levels a pilot randomized controlled study . Hepatology. 27:1998;853-856.
16. Silverman A.L., Piquette D.L., Filipiak C.L., et al. Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels. Am J Gastroenterol. 92:1997;1793-1795.